Skip to main content

Table 1 Correlation between RIZ1 immunoreactivity and clinicopathologic features

From: RIZ1: a potential tumor suppressor in glioma

   RIZ1 immunoreactivity (Median = 8.0)
Features N(N = 51, %) <Median ≥Median P-values
Gender     0.097
 Male 32(62.7) 19 13  
 Female 19(37.3) 6 13  
Age     0.027*
  < 50 years 29(56.9) 12 17  
  ≥ 50 years 22(43.1) 13 9  
Tumor diameter     0.324
  < 6 cm 32(62.7) 14 18  
  ≥ 6 cm 19(37.3) 11 8  
Extent of resection     0.436
 Gross-total 39(76.5) 20 19  
 Sub-total 12(23.5) 5 7  
Pathological grade     0.000*
 Low grade 12(23.5) 1 11  
 High grade 39(76.5) 24 15  
Ki-67 immunoreactivity   
  < Median 24(47.1)  
  ≥ Median 27(52.9)  
  1. * P < 0.05 was considered statistically significant
  2. Table 1: Clinicopathological evaluation suggested that RIZ1 expression was associated with tumor grade (p = 0.000) and patient age (P = 0.027)